atezolizumab,vinorelbine
roche
['ipsos', 'nsclc', 'atezo', 'sclc', 'roche,(-broche),(-rocheter)']
#esmo22 ipsos trial #atezolizumab shows hope to #nsclc ineligible for 1 -line platinum-doublet chemotherapy due to poor ps ( 2) or comorbidities in patients 70y option for vulnerable patients. 
Medical Oncology at https://t.co/hCfxKt8kbP and https://t.co/YeizvuTGR3 Opinions are my own.